A&P LIFESCIENCE FUND, FI
•CLASE B
Valor Liquidativo
Patrimonio
Cartera Renta Variable
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
US5324571083 Lilly (Eli) & Co. | EUR | 190.153 € | 5.75% | 60.05% |
US02043Q1076 Alnylam Pharmaceutic | EUR | 149.933 € | 4.53% | 75.4% |
US00847X1046 Agios Pharmaceutical | EUR | 129.726 € | 3.92% | 99.51% |
US4622221004 Ionis Pharmaceutical | EUR | 111.265 € | 3.37% | 2.92% |
US05464T1043 Axsome Therapeutics | EUR | 104.147 € | 3.15% | 4.22% |
CH0334081137 CRISPR Therapeutics | EUR | 97.453 € | 2.95% | 11.1% |
US92686J1060 Viking Therapeutics | EUR | 97.034 € | 2.93% | 124.31% |
US87164F1057 Syndax Pharmaceutica | EUR | 96.010 € | 2.9% | 24.42% |
US0311621009 Amgen Inc. | EUR | 89.830 € | 2.72% | 27.05% |
US50127T1097 Kura Oncology Inc | EUR | 87.776 € | 2.65% | 47.54% |
US04280A1007 Arrowhead Pharmaceut | EUR | 79.258 € | 2.4% | 1.27% |
US92790C1045 Viridian Therapeutic | EUR | 74.601 € | 2.26% | 6.2% |
US3723032062 Genmab A/S | EUR | 71.944 € | 2.18% | 3.89% |
US1011371077 Accs. Boston Scienti | EUR | 67.140 € | 2.03% | 62.49% |
US85205L1070 SpringWorks Therapeu | EUR | 64.876 € | 1.96% | 6.35% |
US0028241000 Abbott Laboratories | EUR | 62.367 € | 1.89% | 2.72% |
US4923271013 Keros Therapeutics I | EUR | 61.044 € | 1.85% | 34.73% |
US28176E1082 Edwards Lifesciences | EUR | 60.873 € | 1.84% | 48.36% |
US64125C1099 Accs.Neurocrine Bios | EUR | 57.186 € | 1.73% | Nueva |
US8036071004 Sarepta Therapeutics | EUR | 55.602 € | 1.68% | 68.84% |
US45166A1025 Ideaya Biosciences I | EUR | 55.452 € | 1.68% | 1.68% |
IE00BTN1Y115 Medtronic INC | EUR | 52.899 € | 1.6% | 1.55% |
US10806X1028 Bridgebio Pharma Inc | EUR | 51.686 € | 1.56% | Nueva |
US2300311063 Cullinan Oncology In | EUR | 51.280 € | 1.55% | 76.36% |
US74366E1029 Protagonist Therapeu | EUR | 50.909 € | 1.54% | Nueva |
US00287Y1091 AbbVie Inc | EUR | 50.273 € | 1.52% | 42.11% |
US23282W6057 Cytokinetics Inc | EUR | 49.866 € | 1.51% | Nueva |
US5588681057 Madrigal Pharmaceuti | EUR | 47.334 € | 1.43% | Nueva |
US98956P1021 Zimmer Holdings Inc | EUR | 46.905 € | 1.42% | 39.04% |
US35104E1001 4D Molecular Therape | EUR | 44.574 € | 1.35% | Nueva |
US75886F1075 Regeneron Pharmaceut | EUR | 44.149 € | 1.34% | 23.31% |
US9250501064 Verona Pharma PLC | EUR | 39.494 € | 1.19% | 16.71% |
US36266G1076 GE HealthCare Techno | EUR | 38.258 € | 1.16% | 82.68% |
US6047491013 Mirum Pharmaceutical | EUR | 38.297 € | 1.16% | Nueva |
US8835561023 Thermo Electron Corp | EUR | 35.617 € | 1.08% | 7.35% |
US6031701013 Mineralys Therapeuti | EUR | 35.298 € | 1.07% | 40.19% |
US07725L1026 Beigene ltd-adr | EUR | 34.226 € | 1.04% | 18.49% |
US2358511028 Danaher Corp | EUR | 34.284 € | 1.04% | 11.29% |
US15117B2025 Celldex Therapeutics | EUR | 32.716 € | 0.99% | 31.59% |
US7291391057 Pliant Therapeutics | EUR | 31.930 € | 0.97% | 20.5% |
US7611521078 Resmed Inc | EUR | 31.626 € | 0.96% | 14.66% |
US04335A1051 Arvinas Inc | EUR | 31.359 € | 0.95% | 33.36% |
US22663K1079 Crinetics Pharmaceut | EUR | 30.437 € | 0.92% | Nueva |
US80105N1054 Sanofi (Eff Aquitain | EUR | 29.167 € | 0.88% | 50.92% |
US03152W1099 Amicus Therapeutics | EUR | 28.640 € | 0.87% | 27.97% |
US7711951043 ROCHE HOLDING | EUR | 27.411 € | 0.83% | 1.4% |
US77313F1066 Rocket Pharmaceutica | EUR | 26.408 € | 0.8% | Nueva |
US5015751044 Kymera Therapeutics | EUR | 26.136 € | 0.79% | 110.25% |
US0758871091 Becton Dickinson | EUR | 25.961 € | 0.79% | 52.64% |
US87583X1090 Tango Therapeutics I | EUR | 24.027 € | 0.73% | Nueva |
US09627Y1091 Blueprint Medicines | EUR | 23.844 € | 0.72% | 20.41% |
US00973Y1082 Akero Therapeutics I | EUR | 23.432 € | 0.71% | 3.53% |
US2825591033 89bio Inc | EUR | 23.328 € | 0.71% | 26.11% |
US70975L1070 Penumbra Inc | EUR | 22.847 € | 0.69% | 26.28% |
KY61559X1045 MoonLake Immunothera | EUR | 18.716 € | 0.57% | Nueva |
US66987V1098 NOVARTIS AG-REG SHS | EUR | 18.981 € | 0.57% | 45.82% |
US03969K1088 Arcutis Biotherapeut | EUR | 10.574 € | 0.32% | Nueva |
US6409791000 Neumora Therapeutics | EUR | 4377 € | 0.13% | Nueva |
US92338C1036 Veralto Corp | EUR | 4367 € | 0.13% | 19.61% |
US7999261008 Sandoz Group AG | EUR | 2568 € | 0.08% | 16.52% |
US6418711080 Ambrx Biopharma Inc | EUR | 0 € | 0% | Vendida |
US19240Q2012 Cogent Biosciences I | EUR | 0 € | 0% | Vendida |
US92337C2035 Verastem Inc | EUR | 0 € | 0% | Vendida |
US48576A1007 Karuna Therapeutics | EUR | 0 € | 0% | Vendida |
US8808811074 Terns Pharmaceutical | EUR | 0 € | 0% | Vendida |
US00445A1007 ACELYRIN Inc | EUR | 0 € | 0% | Vendida |
US89422G1076 Travere Therapeutics | EUR | 0 € | 0% | Vendida |
US67080M1036 Nurix Therapeutics I | EUR | 0 € | 0% | Vendida |
US24823R1059 Denali Therapeutics | EUR | 0 € | 0% | Vendida |
US38000Q1022 GlycoMimetics Inc | EUR | 0 € | 0% | Vendida |
US98401F1057 Xencor Inc | EUR | 0 € | 0% | Vendida |
US45253H1014 ImmunoGen Inc | EUR | 0 € | 0% | Vendida |
US40131M1099 Guardant Health Inc | EUR | 0 € | 0% | Vendida |
US60468T1051 Mirati Therapeutics | EUR | 0 € | 0% | Vendida |
US30063P1057 Exact Sciences Corp | EUR | 0 € | 0% | Vendida |
US09061G1013 Biostar Pharmaceutic | EUR | 0 € | 0% | Vendida |
2024-Q2
Renta Variable Internacional
EUR
86.472,18
86
0
100
562.235 €
6,5 €
Política de Inversión
Operativa con derivados
Sectores
- Salud
97.27%
- No Clasificado
2.73%
Regiones
- Estados Unidos
94.56%
- Europa
4.84%
- China
0.60%
Tipo de Inversión
- Small Cap - Growth
21.60%
- Small Cap - Value
17.93%
- Large Cap - Growth
14.80%
- Large Cap - Blend
10.69%
- Small Cap - Blend
9.79%
- Medium Cap - Growth
8.42%
- Large Cap - Value
3.32%
- Medium Cap - Blend
3.30%
- Medium Cap - Value
3.14%
- No Clasificado
7.03%
Comisiones
Comisión de gestión
0.67
Patrimonio
Comisión de depositario
0.04
Gastos
Trimestral
0.42
0.41
0.47
0.41
Anual
1.94
0.69
0.69